Drug Shortage Report for TOBI

Last updated on 2023-01-23 History
Report ID 173402
Drug Identification Number 02239630
Brand name TOBI
Common or Proper name TOBRAMYCIN
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 300MG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging size 56 AMPULES
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-12-21
Actual start date 2022-11-21
Estimated end date 2023-04-11
Actual end date
Shortage status Actual shortage
Updated date 2023-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2023-01-23 French Compare
v13 2023-01-23 English Compare
v12 2023-01-17 French Compare
v11 2023-01-17 English Compare
v10 2023-01-10 French Compare
v9 2023-01-10 English Compare
v8 2022-12-22 English Compare
v7 2022-11-17 French Compare
v6 2022-11-17 English Compare
v5 2022-11-09 French Compare
v4 2022-11-09 English Compare
v3 2022-11-09 English Compare
v2 2022-11-03 French Compare
v1 2022-11-03 English Compare

Showing 1 to 14 of 14